Mary Chapman, features writer —

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

MDA Shamrocks fundraising campaign takes the field for 2023

Thousands of retailers across the U.S. are helping the Muscular Dystrophy Association (MDA) kick off MDA Shamrocks, its annual fundraising campaign in support of those living with muscular dystrophy, amyotrophic lateral sclerosis, and other neuromuscular disorders (NMDs). Money raised through the effort — said to be…

CITGO Raises $2.3M to Aid MDA, Neuromuscular Patient Community

CITGO raised $2.3 million this year to help advance research, improve patient care, and bolster advocacy efforts for the neuromuscular community, continuing its long-standing support for the Muscular Dystrophy Association (MDA), . Throughout the year, employees of the Houston, Texas-based petroleum company, along with vendors, contractors, marketers,…

PPMD, Duchenne UK Call for Research Proposals for Treatments

Parent Project Muscular Dystrophy (PPMD) and Duchenne UK will jointly award up to $1 million to two research projects that seek to develop new treatments for Duchenne muscular dystrophy (DMD), especially those involving cell and gene therapy. The call for proposals for projects, which are expected…

Raising Hope for Muscular Dystrophy This Awareness Month

Note: This story was updated Aug. 31, 2022, to clarify that MDA Advocate Madison Lawson will throw out the honorary pitch at the Cardinals game alongside Donald S. Wood. Supporters across the country are poised to mark National Muscular Dystrophy Awareness Month, observed each September in the U.S. The…

Defeat Duchenne Canada Grants $1M to DMD Treatment Research

Defeat Duchenne Canada is investing $1.14 million in three research projects aimed at providing better treatments for Duchenne muscular dystrophy, the most common type of muscular dystrophy and one that affects about 1 in 3,500 male births. The trio of three-year projects joins six other research efforts…

MDA Campaigns Support Summer Camp, NMD Community

To help support its popular summer camp and the neuromuscular disease community, the Muscular Dystrophy Association (MDA) has launched campaigns through October that involve more than 1,000 retailers nationwide. Proceeds from the MDA’s summer retail campaigns will benefit research, care, and advocacy for those living with muscular…

Muscular Dystrophy Association Adds 13 New Care Centers in US

Thirteen new hospitals and health institutions have been added to the Muscular Dystrophy Association’s MDA Care Center Network, expanding the network’s reach across the United States. These additions, which comprise more than 150 care centers, include 10 new grant awards as well as three care affiliates that have been…

CureDuchenne Invests $1M in Gennao Bio’s Effort to Find Therapies

Genetic medicines company Gennao Bio will use a $1 million CureDuchenne Ventures investment to help expand its gene monoclonal antibody (GMAB) platform technology, which is now applied to rare muscle disorders, including Duchenne muscular dystrophy (DMD). The initial focus of the nonviral delivery system Gennao Bio is…